Even though it happened about 15 years ago, I’ll never forget when the hives started to develop. I was working the midnight shift as a nurse, and sleeping during the day. It didn’t seem like a big ...

Overall, the CUPID-C trial corroborates earlier evidence that dupilumab can meaningfully reduce itch and hives in ...

Patients with chronic spontaneous urticaria had positive outcomes weeks after barzolvolimab, according to data presented at ...

With barzolvolimab re-treatment, 62% of patients with ColdU and 60% of patients with SD had a complete response at Week 20 in the OLE. These findings are consistent with the complete response rates in ...

Regeneron and Sanofi win CHMP backing to expand Dupixent use to young CSU patients, with EU and U.S. decisions poised to unlock a new growth avenue.

Improvements in urticaria control and quality of life among patients with chronic inducible urticaria were observed with 20 ...

Medically reviewed by Katlein Franca, MD Doctors use a process of elimination to diagnose chronic hives, rather than a single ...

(BPT) – If you’ve had hives, you know how challenging they can be. But you may not know that there is more than one type of hives, or urticaria, and that treatments are available. A brief episode of ...

In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than the placebo group.

Barzolvolimab improved symptoms in chronic spontaneous urticaria, supporting mast cell targeting as a novel treatment strategy. Read more.

Chronic urticaria is an inflammatory skin disorder characterised by recurrent transient wheals and/or angioedema that persist for more than six weeks. Within this spectrum, chronic spontaneous ...